Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration

BACKGROUND: The aim of our study was to evaluate the functional and anatomic outcomes of intravitreal ranibizumab for the treatment of symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration. METHODS: This was a prospective, single...

Descripción completa

Detalles Bibliográficos
Autores principales: Gallego-Pinazo, Roberto, Marina, Ana, Suelves-Cogollos, Francés-Muñoz, Ester, Millán, J María, Arevalo, J Fernando, Mullor, J Luis, Díaz-Llopis, Manuel
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045064/
https://www.ncbi.nlm.nih.gov/pubmed/21383943
http://dx.doi.org/10.2147/OPTH.S15832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045064/
https://www.ncbi.nlm.nih.gov/pubmed/21383943
http://dx.doi.org/10.2147/OPTH.S15832

Ejemplares similares